Assessment if a Daily SMS (Short Message System) Reminder Improves the Adherence of COPD Patients to Therapy With Spiriva 18 Microgram.
Phase of Trial: Phase IV
Latest Information Update: 20 Dec 2012
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 14 Dec 2011 Actual patient number is 96 as reported by ClinicalTrials.gov.
- 14 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.